Cerus (CERS) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cerus | 549.42 Mn | 469.73 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.66% |
| Dec 31, 2025 | 0.85% |
| Sep 30, 2025 | 3.02% |
| Jun 30, 2025 | 3.84% |
| Mar 31, 2025 | 12.06% |
| Dec 31, 2024 | 8.27% |
| Sep 30, 2024 | 10.15% |
| Jun 30, 2024 | 12.59% |
| Mar 31, 2024 | 15.26% |
| Dec 31, 2023 | 11.74% |
| Sep 30, 2023 | 8.30% |
| Jun 30, 2023 | 17.14% |
| Mar 31, 2023 | 19.62% |
| Dec 31, 2022 | 25.32% |
| Sep 30, 2022 | 19.26% |
| Jun 30, 2022 | 15.18% |
| Mar 31, 2022 | 24.52% |
| Dec 31, 2021 | 25.51% |
| Sep 30, 2021 | 22.87% |
| Jun 30, 2021 | 22.73% |
| Mar 31, 2021 | 24.60% |
| Dec 31, 2020 | 21.04% |
| Sep 30, 2020 | 22.82% |
| Jun 30, 2020 | 22.53% |
| Mar 31, 2020 | 20.56% |
| Dec 31, 2019 | 21.65% |
| Sep 30, 2019 | 19.46% |
| Jun 30, 2019 | 18.54% |
| Mar 31, 2019 | 24.95% |
| Dec 31, 2018 | 26.97% |
| Sep 30, 2018 | 25.41% |
| Jun 30, 2018 | 25.26% |
| Mar 31, 2018 | 26.56% |
| Dec 31, 2017 | 30.09% |
| Sep 30, 2017 | 28.03% |
| Jun 30, 2017 | 29.66% |
| Mar 31, 2017 | 31.69% |
| Dec 31, 2016 | 35.24% |
| Sep 30, 2016 | 35.36% |
| Jun 30, 2016 | 35.84% |
| Mar 31, 2016 | 30.35% |
| Dec 31, 2015 | 28.05% |
| Sep 30, 2015 | 28.14% |